Johnson and Johnson: Why Transparency is Critical for Patients
November 13, 2024
November 13, 2024
NEW BRUNSWICK, New Jersey, Nov. 13 -- Johnson and Johnson issued the following agency statement on Nov. 12, 2024:
* * *
Johnson & Johnson (J&J) works to expand equitable patient access every day. This includes our long-standing participation in the 340B Program which serves as an important safety net for vulnerable patients. J&J supports the original intent of the 340B Program.
J&J is acting now to support the 340B Program's long-term sustai . . .
* * *
Johnson & Johnson (J&J) works to expand equitable patient access every day. This includes our long-standing participation in the 340B Program which serves as an important safety net for vulnerable patients. J&J supports the original intent of the 340B Program.
J&J is acting now to support the 340B Program's long-term sustai . . .